fda bpc 157 compounding category 2 list 1 vs. Category 2. The FDA's peptide update, explained. Category peptides are on the FDA's “difficult to compound” list, which effectively blocks licensed pharmacies from producing them. Category 1 means Regulatory Alert: FDA's April 2026
Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law 83% of peptide aware Americans want the FDA to make peptides more accessible AOL RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA's Overreach on Compounded Peptides
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



